SCHEMBL5752507

SCHEMBL5752507

CC(OC(C(=O)c1cccnc1)C(OC(C)c1cc(S(=O)(=O)N2CCCCC2)ccc1Cl)C(=O)c1ccccn1)c1cc(S(=O)(=O)N2CCCCC2)ccc1Cl

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.48
MAPT P10636 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
ALDH1A1 P00352 5/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
LMNA P02545 2/20 0.43
PKM P14618 1/20 0.42
KMT2A Q03164 5/20 0.42
MEN1 O00255 4/20 0.42
HTT P42858 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CRHBP P24387 1/20 0.42
RAB9A P51151 1/20 0.42
CRHR2 Q13324 1/20 0.42
CNR1 P21554 2/20 0.42
POLB P06746 1/20 0.42
HSD17B10 Q99714 1/20 0.41
TSHR P16473 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4713063 0.78 MAPT (0.54) MAPK1MAPTNPSR1ALDH1A1SMN1; SMN2
SCHEMBL4713564 0.77 MAPK1 (0.55) MAPK1ALDH1A1SMN1; SMN2LMNAKMT2A
SCHEMBL4714610 0.73 MAPK1 (0.55) MAPK1MAPTNPSR1ALDH1A1SMN1; SMN2
SCHEMBL8315142 0.70 MAPK1 (0.52) MAPK1ALDH1A1SMN1; SMN2LMNAKMT2A
SCHEMBL4715672 0.68 MAPT (0.65) MAPK1MAPTNPSR1ALDH1A1SMN1; SMN2
SCHEMBL4715768 0.67 MAPT (0.56) MAPK1MAPTNPSR1ALDH1A1SMN1; SMN2
SCHEMBL4716402 0.67 ALDH1A1 (0.58) MAPK1MAPTNPSR1ALDH1A1SMN1; SMN2
SCHEMBL4713091 0.66 ALDH1A1 (0.54) MAPK1ALDH1A1SMN1; SMN2LMNAKMT2A
SCHEMBL4714806 0.66 MAPT (0.54) MAPK1MAPTNPSR1ALDH1A1SMN1; SMN2
SCHEMBL4714178 0.66 LMNA (0.57) MAPK1MAPTNPSR1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1615904-A2 SUBSTITUTED BENZOSULPHONAMIDE AS POTENTIATORS OF GLUTAMATE RECEPTORS AstraZeneca AB (SE) 2006-01-18 EP disclosed
WO-2004092135-A2 SUBSTITUTED BENZOSULPHONAMIDE AS POTENTIATORS OF GLUTAMATE RECEPTORS ASTRAZENECA (SE) 2004-10-28 WO disclosed